By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Vanda Pharmaceuticals, Inc. 

9620 Medical Center Drive
Suite 201
Rockville  Maryland  20850  U.S.A.
Phone: 301-294-9300 Fax: 301-294-1900


SEARCH JOBS


Industry
Pharmaceutical






Company News
Vanda Pharmaceuticals, Inc. (VNDA) To Present At The Canaccord Genuity Annual Growth Conference 8/10/2015 10:25:19 AM
Vanda Pharmaceuticals, Inc. (VNDA) Release: HETLIOZ (tasimelteon) Phase III SET And RESET Trial Results Published In The Lancet 8/5/2015 10:44:05 AM
Vanda Pharmaceuticals, Inc. (VNDA) Announces Listing Of Four New Fanapt Patents In The FDA Orange Book 8/3/2015 6:48:38 AM
Vanda Pharmaceuticals, Inc. (VNDA) Reports Second Quarter 2015 Financial Results 7/30/2015 12:48:51 PM
Vanda Pharmaceuticals, Inc. (VNDA) To Announce Second Quarter 2015 Financial Results On July 29, 2015 7/9/2015 10:24:08 AM
Vanda Pharmaceuticals, Inc. (VNDA) Release: HETLIOZ Receives European Commission Approval For The Treatment Of Non-24-Hour Sleep-Wake Disorder In The Totally Blind 7/8/2015 6:59:05 AM
Vanda Pharmaceuticals, Inc. (VNDA) Announces Listing Of A New HETLIOZ Patent In The FDA Orange Book 7/2/2015 7:30:58 AM
Vanda Pharmaceuticals, Inc. (VNDA) Announces Positive Results From The Relapse Prevention Study In Patients With Schizophrenia (REPRIEVE) Demonstrating The Long-Term Maintenance Effects Of Fanapt (iloperidone) 6/24/2015 9:19:52 AM
Vanda Pharmaceuticals, Inc. (VNDA) To Present At The JMP Securities Life Sciences Conference 6/19/2015 8:08:09 AM
Vanda Pharmaceuticals, Inc. (VNDA) To Present At The Jefferies and Co. 2015 Global Healthcare Conference 6/3/2015 10:48:43 AM
12345678910...
//-->